Dyslipidemia and cardiovascular risk: the importance of early prevention

AUTOR(ES)

Miller, M.

FONTE

Oxford University Press

RESUMO

Strategies aimed at primary prevention provide an outstanding opportunity for reducing the onset and burden of cardiovascular (CV) disease. Lipid abnormalities, including high levels of low-density lipoprotein cholesterol (LDL-C), elevated triglycerides and low levels of high-density lipoprotein cholesterol (HDL-C), are associated with an increased risk of CV events, thereby serving as contributors to this process. By consensus, lowering LDL-C, generally with statin therapy, is the primary target of lipid-lowering therapy. However, statin therapy may be insufficient for patients with mixed dyslipidemia, especially those with insulin resistance syndromes. While the addition of niacin, fibrate or omega-3 fatty acids may be useful in this setting, outcomes data are lacking. Therefore, data from ongoing prospective studies will hopefully resolve this issue and facilitate identification of optimal strategies to augment CV risk reduction.

Documentos Relacionados

• Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention1234
• Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children
• Oral Contraceptives and Cardiovascular Risk: Adding Clinical Evidence to the Pathophysiology
• Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update
• The Importance of Cardiovascular Risk in Primary Healthcare